Insider trades

Kaitlyn Arsenault, CFO of Skye Bioscience SKYE, has filed 0 purchases and 4 sales on the open market. The latest trade was on 02/06.

Kaitlyn Arsenault

CFO
First filing
23/08/29
Trades
15 trades
Buys / sales
0 / 4
12-month net buying
No record
Last trade
02/06

Trading activity

Transactions

Trade type
SKYE
Open-market saleAmendment24/11/15–24/11/1825/02/2843,216 sh2 trades$4.99avg.$215,754.24−20.5%
SKYE
Open-market sale24/11/15–24/11/1824/11/1943,396 sh2 trades$4.99avg.$216,652.44−20.7%